SENORES PHARMACEUTICALS L (SENORES) — Cash Flow Quality Index
SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow Quality Index of 0.46x as of September 2025. Operating cash flow of Rs242.20 Million is below net income of Rs521.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore SENORES asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SENORES PHARMACEUTICALS L Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for SENORES PHARMACEUTICALS L across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SENORES PHARMACEUTICALS L tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for SENORES PHARMACEUTICALS L (2022–2025)
Year-by-year earnings quality comparison for SENORES PHARMACEUTICALS L. For live market cap and the full company financial profile, see SENORES PHARMACEUTICALS L (SENORES) total market value.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.65x | Rs-459.20 Million | Rs705.70 Million | ▲ +20.4% |
| 2024 | -0.82x | Rs-257.00 Million | Rs314.55 Million | ▼ -538.6% |
| 2023 | -0.13x | Rs-10.79 Million | Rs84.33 Million | ▲ +98.8% |
| 2022 | -10.54x | Rs-104.47 Million | Rs9.91 Million | — |